Jun 26, 2007
110th Congress, 2007–2009
Died in a previous Congress
This bill was introduced on June 27, 2007, in a previous session of Congress, but was not enacted.
Senator from Massachusetts
Read Text »
Last Updated: Nov 19, 2008
Length: 88 pages
About the bill
A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.
The bill’s titles are written by its sponsor.
This is the first step in the legislative process.
Reported by Committee
A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007. Retrieved from https://www.govtrack.us/congress/bills/110/s1695
“S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007.” www.GovTrack.us. 2007. August 25, 2016 <https://www.govtrack.us/congress/bills/110/s1695>
|title=S. 1695 (110th)
|accessdate=August 25, 2016
|author=110th Congress (2007)
|date=June 26, 2007
|quote=Biologics Price Competition and Innovation Act of 2007